Persistence and Failure Rates of Monotherapy Etanercept in Biologic-Naïve Psoriasis Patients: A Retrospective Study. | J Drugs Dermatol;15(8): 1029-30, 2016 Aug 01. | MEDLINE

Main content 1 Search 2 Footer 3

+A A -A High contrast

VHL Regional Portal

Information and Knowledge for Health

Advanced Search EVID@Easy

Persistence and Failure Rates of Monotherapy Etanercept in Biologic-Naïve Psoriasis Patients: A Retrospective Study.

Reddy, Shivani P; Shah, Vidhi V; Lin, Elaine J; Egeberg, Alexander; Wu, Jashin J.

J Drugs Dermatol ; 15(8): 1029-30, 2016 Aug 01.

Article in En | MEDLINE | ID: mdl-27538008

Subject(s)

Search on Google

Collection: 01-internacional Database: MEDLINE Main subject: Psoriasis / Biological Products / Anti-Inflammatory Agents, Non-Steroidal / Etanercept Type of study: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Female / Humans / Male Language: En Journal: J Drugs Dermatol Journal subject: DERMATOLOGIA Year: 2016 Document type: Article Country of publication:

Search on Google

Collection: 01-internacional Database: MEDLINE Main subject: Psoriasis / Biological Products / Anti-Inflammatory Agents, Non-Steroidal / Etanercept Type of study: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Female / Humans / Male Language: En Journal: J Drugs Dermatol Journal subject: DERMATOLOGIA Year: 2016 Document type: Article Country of publication: